UY34964A - Derivados de cromano como inhibidores del receptor transitorio potencial de la melastatina 8 (trpm8) - Google Patents
Derivados de cromano como inhibidores del receptor transitorio potencial de la melastatina 8 (trpm8)Info
- Publication number
- UY34964A UY34964A UY0001034964A UY34964A UY34964A UY 34964 A UY34964 A UY 34964A UY 0001034964 A UY0001034964 A UY 0001034964A UY 34964 A UY34964 A UY 34964A UY 34964 A UY34964 A UY 34964A
- Authority
- UY
- Uruguay
- Prior art keywords
- trpm8
- inhibitors
- melastatin
- receiver
- chroman derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Los compuestos de cromano y derivados de Fórmula I son inhibidores útiles del TRPM8. Los compuestos son útiles para tratar una cantidad de trastornos y condiciones mediadas por el TRPM8 y se pueden usar para preparar medicamentos y composiciones farmacéuticas útiles en el tratamiento de tales trastornos y condiciones. Los ejemplos de tales trastornos incluyen, no taxativamente, la migraña y el dolor neuropático. Los compuestos de fórmula I tienen la siguiente estructura, donde las definiciones de las variables se proveen en la presente solicitud.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261680199P | 2012-08-06 | 2012-08-06 | |
US201361847867P | 2013-07-18 | 2013-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34964A true UY34964A (es) | 2014-02-28 |
Family
ID=48949292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034964A UY34964A (es) | 2012-08-06 | 2013-08-06 | Derivados de cromano como inhibidores del receptor transitorio potencial de la melastatina 8 (trpm8) |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR092064A1 (es) |
TW (1) | TW201418240A (es) |
UY (1) | UY34964A (es) |
WO (1) | WO2014025651A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015136947A1 (en) | 2014-03-14 | 2015-09-17 | Raqualia Pharma Inc. | Azaspiro derivatives as trpm8 antagonists |
AU2015342883B2 (en) | 2014-11-06 | 2020-07-02 | Bial - R&D Investments, S.A. | Substituted pyrrolo(1,2-a)pyrimidines and their use in the treatment of medical disorders |
CA2966583A1 (en) | 2014-11-06 | 2016-05-12 | Lysosomal Therapeutics Inc. | Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders |
ES2958391T3 (es) | 2014-11-06 | 2024-02-08 | Bial R&D Invest S A | Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos |
EP3156405A1 (en) * | 2015-10-13 | 2017-04-19 | Boehringer Ingelheim International GmbH | Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxamide |
KR20230104752A (ko) | 2016-04-06 | 2023-07-10 | 비알 - 알&디 인베스트먼츠, 에스.에이. | 피라졸로[1,5-a]피리미디닐 카르복스아미드 화합물및 의학적 장애의 치료에서의 그의 용도 |
EP3440081A4 (en) | 2016-04-06 | 2019-09-18 | Lysosomal Therapeutics Inc. | PYRROLO [1,2-A] PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
CA3020305A1 (en) | 2016-04-06 | 2017-10-12 | Lysosomal Therapeutics Inc. | Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
WO2017192931A1 (en) | 2016-05-05 | 2017-11-09 | Lysosomal Therapeutics Inc. | SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
CA3022670A1 (en) | 2016-05-05 | 2017-11-09 | Lysosomal Therapeutics Inc. | Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders |
EP3609868B1 (en) | 2017-03-13 | 2023-10-18 | RaQualia Pharma Inc. | Tetrahydroquinoline derivatives as p2x7 receptor antagonists |
WO2022150962A1 (en) | 2021-01-12 | 2022-07-21 | Westlake Pharmaceutical (Hangzhou) Co., Ltd. | Protease inhibitors, preparation, and uses thereof |
WO2024099393A1 (zh) * | 2022-11-09 | 2024-05-16 | 中国科学院上海药物研究所 | 一类含芳基的胺类化合物、其制备方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010002558A1 (de) * | 2009-11-20 | 2011-06-01 | Symrise Ag | Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe |
-
2013
- 2013-08-02 WO PCT/US2013/053514 patent/WO2014025651A1/en active Application Filing
- 2013-08-06 AR ARP130102798A patent/AR092064A1/es unknown
- 2013-08-06 TW TW102128148A patent/TW201418240A/zh unknown
- 2013-08-06 UY UY0001034964A patent/UY34964A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2014025651A1 (en) | 2014-02-13 |
AR092064A1 (es) | 2015-03-18 |
TW201418240A (zh) | 2014-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34964A (es) | Derivados de cromano como inhibidores del receptor transitorio potencial de la melastatina 8 (trpm8) | |
ECSP22091792A (es) | Compuestos tricíclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroplastos | |
ECSP18094790A (es) | Piridinas sustituidas con heteroarilo y métodos de uso referencia cruzada a solicitudes relacionadas | |
DOP2016000041A (es) | Compuestos derivados de 5,5,7,7-tetrametil-5,7-dihidro-4h-tieno[2,3-c]piran-3-carboxamida que son moduladores del regulador de la conductancia transmembrana de la fibrosis quística (cftr) | |
CU20130036A7 (es) | Triazina-oxidazoles | |
PH12015501289B1 (en) | Novel benzimidazole derivatives as ep4 antagonists | |
CO6781507A2 (es) | Novedosos derivados heterociclicos | |
BR112016000909A8 (pt) | derivados piperidinil indólicos, seus usos, e combinação e composição farmacêuticas | |
CO6670575A2 (es) | Aminopirazoloqinazolinas sustituidas, útiles en el tratamiento de enfermedades proliferativas y composiciones farmaceúticas que las continen | |
CO6771417A2 (es) | Antagonistas del receptor de ácido lisofosfatidico y su uso en el tratamiento de fibrosis | |
CO6852073A2 (es) | Antagonistas trpm8 y su uso en tratamientos | |
UY35142A (es) | Derivados de triazolopirazinas como inhibidores de brd4 | |
EA201591051A1 (ru) | Ингибиторы erk и варианты их применения | |
UY35213A (es) | Compuestos del tipo de las carbamilpiridonas policíclicas y su uso farmaceutico | |
CO6700831A2 (es) | Derivados de pirazina como bloqueadores de enac | |
PE20190181A1 (es) | Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas | |
ECSP17046848A (es) | Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de desórdenes inflamatorios y osteoartritis | |
GEP201706671B (en) | Heterocyclyl compounds as mek inhibitors | |
CU20160180A7 (es) | Compuestos de dihidroisoquinolinona sustituida | |
UY35146A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
UY36702A (es) | Piridinas sustituidas y métodos de uso | |
PE20150709A1 (es) | Benzamidas | |
ECSP14024526A (es) | Derivados bicíclicos de pirazinona | |
SV2016005294A (es) | 2-amino-6-metil-4,4a,5,6-tetrahidropirano(3,4-d)(1,3)tiazin-8a(8h)-il-1,3-tiazol-4-ilamidas | |
CR20140516A (es) | Compuestos de pirazol sustituidos como antagonistas de lpar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20210609 |